[
    {
        "molecule_name": "compounds of Formula I",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<5000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula I inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula I inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compounds of Formula I",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<5000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula I inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula I inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula I",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<2000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula I inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula I inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula I",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<1500",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula I inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula I inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula I",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<800",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula I inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula I inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula I",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<500",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula I inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula I inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula I",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<250",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula I inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula I inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula I",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<150",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula I inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula I inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula I",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<50",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula I inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula I inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<5000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula I inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula I inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<1000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula I inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula I inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<750",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula I inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula I inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<500",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula I inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula I inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<250",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula I inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula I inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<100",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula I inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula I inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<50",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula I inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula I inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compounds of Formula II",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<5000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula II inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula II inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compounds of Formula II",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<5000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula II inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula II inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula II",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<2000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula II inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula II inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula II",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<1500",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula II inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula II inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula II",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<800",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula II inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula II inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula II",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<500",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula II inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula II inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula II",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<250",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula II inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula II inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula II",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<150",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula II inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula II inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula II",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<50",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula II inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula II inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<5000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula II inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula II inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<1000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula II inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula II inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<750",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula II inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula II inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<500",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula II inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula II inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<250",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula II inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula II inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<100",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula II inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula II inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<50",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula II inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula II inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compounds of Formula III",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<5000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula III inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula III inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compounds of Formula III",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<5000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula III inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula III inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula III",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<2000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula III inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula III inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula III",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<1500",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula III inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula III inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula III",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<800",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula III inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula III inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula III",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<500",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula III inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula III inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula III",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<250",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula III inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula III inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula III",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<150",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula III inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula III inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula III",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<50",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula III inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula III inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<5000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula III inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula III inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<1000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula III inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula III inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<750",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula III inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula III inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<500",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula III inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula III inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<250",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula III inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula III inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<100",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula III inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula III inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<50",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula III inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula III inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compounds of Formula IV",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<5000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula IV inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula IV inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compounds of Formula IV",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<5000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula IV inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula IV inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula IV",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<2000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula IV inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula IV inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula IV",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<1500",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula IV inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula IV inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula IV",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<800",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula IV inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula IV inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula IV",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<500",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula IV inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula IV inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula IV",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<250",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula IV inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula IV inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula IV",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<150",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula IV inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula IV inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula IV",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<50",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula IV inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula IV inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<5000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula IV inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula IV inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<1000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula IV inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula IV inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<750",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula IV inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula IV inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<500",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula IV inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula IV inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<250",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula IV inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula IV inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<100",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula IV inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula IV inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<50",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula IV inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula IV inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compounds of Formula V",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<5000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula V inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula (V) inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compounds of Formula V",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<5000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula V inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula (V) inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula (V)",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<2000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula V inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula (V) inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula (V)",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<1500",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula V inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula (V) inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula (V)",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<800",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula V inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula (V) inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula (V)",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<500",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula V inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula (V) inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula (V)",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<250",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula V inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula (V) inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula (V)",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<150",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula V inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula (V) inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula (V)",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<50",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula V inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula (V) inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<5000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula V inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula (V) inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<1000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula V inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula (V) inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<750",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula V inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula (V) inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<500",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula V inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula (V) inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<250",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula V inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula (V) inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<100",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula V inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula (V) inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<50",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula V inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula (V) inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compounds of Formula VI",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<5000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula VI inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula VI inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compounds of Formula VI",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<5000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula VI inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula VI inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula VI",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<2000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula VI inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula VI inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula VI",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<1500",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula VI inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula VI inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula VI",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<800",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula VI inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula VI inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula VI",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<500",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula VI inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula VI inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula VI",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<250",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula VI inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula VI inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula VI",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<150",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula VI inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula VI inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "compound of Formula VI",
        "protein_target_name": "SHMT2",
        "binding_metric": "IC50",
        "value": "<50",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula VI inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula VI inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<5000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula VI inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula VI inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<1000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula VI inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula VI inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<750",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula VI inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula VI inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<500",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula VI inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula VI inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<250",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula VI inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula VI inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<100",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula VI inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula VI inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    },
    {
        "molecule_name": "such compounds",
        "protein_target_name": "SHMT1",
        "binding_metric": "IC50",
        "value": "<50",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, compounds of Formula VI inhibit SHMT2 with an IC50 of less than 5000 nM and, optionally, inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, compound of Formula VI inhibit SHMT2 with an IC50 of less than 2000 nM, less than 1500 nM, less than 800 nM, less than 500 nM, less than 250 nM, less than 150 nM, or less than 50 nM.\nIn certain embodiments, such compounds also inhibit SHMT1 with an IC50 of less than 5000 nM.\nIn certain embodiments, such compounds inhibit SHMT1 with an IC50 of less than 1000 nM, less than 750 nM, less than 500 nM, less than 250 nM, less than 100 nM, or less than 50 nM."
    }
]